Quality of Anticoagulation Management Among Patients With Atrial Fibrillation

Open Access

10 April 2000

journal article
review article
Published by American Medical Association (AMA) in Archives of internal medicine (1960)

Vol. 160 (7) , 967-973
https://doi.org/10.1001/archinte.160.7.967

Abstract

ATRIAL FIBRILLATION (AF) is the second strongest risk factor for stroke and can increase the risk for stroke 5-fold.¹ Randomized trials have shown that treatment with warfarin sodium decreases the risk for stroke by 60% to 70% in comparison with a decrease of 20% to 25% with aspirin.² Various guidelines and consensus statements support the use of warfarin among patients with AF.³^,4